Lymphatica Medtech

Lymphatica Medtech is a private, clinical-stage medical device company pioneering treatments for lymphatic system disorders, with a primary focus on lymphedema. Its core technology involves a minimally invasive, implantable microsurgical device designed to restore lymphatic drainage by creating permanent anastomoses (connections) between lymphatic vessels and veins. The company is advancing its lead program through clinical trials in Europe and is positioned to tap into a large, underserved market with limited effective treatment options. As a pre-revenue entity, it has secured venture capital and grant funding to support its development.

Minimally invasive, implantable microsurgical device platform for automated lymphovenous anastomosis (LVA) to restore lymphatic drainage.

Direct competition in automated LVA devices is currently limited, positioning Lymphatica as a potential first-mover. However, it competes indirectly with established palliative care (compression garments, pumps) and other surgical techniques (vascularized lymph node transfer). Larger medtech firms may enter the space if the clinical and commercial promise is validated.